Evidence map›Paper›PMID 25210145›Full record

ReviewJournal of leukocyte biology2014

Complement modulation of T cell immune responses during homeostasis and disease.

Elizabeth V Clarke, Andrea J Tenner

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Causal relationship between complementFrontiers in genetics · 2024
    Article
  6. Complement, complosome, and complotype: A perspective.European journal of immunology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Durability of transgene expression after rAAV gene therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  11. A clinical approach to children with C3 glomerulopathy.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  12. Review
  13. Review
  14. International journal of molecular sciences · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Editorial: The Role of Complement in Tumors.Frontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Elizabeth V ClarkeDepartment of Molecular Biology and Biochemistry and Institute for Immunology, University of California, Irvine, California, USA evclarke@uci.edu.
Andrea J TennerDepartment of Molecular Biology and Biochemistry and Institute for Immunology, University of California, Irvine, California, USA.
University of California, Irvine · US

Funding

INTERACTION OF CLQ ON PHAGOCYTIC CELLSR01AI041090 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI TENNER, ANDREA JOAN · 1996 to 2010
$3.1M
Immunology Research Training ProgramT32AI060573 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEARLMAN, ERIC · 2005 to 2020
$1.9M
NIAID NIH HHS AI-41090NIAID NIH HHS R01 AI041090NIAID NIH HHS T32 AI060573NIAID NIH HHS T32 AI 605730
6 · The paper itself

Abstract

The complement system is an ancient and critical effector mechanism of the innate immune system as it senses, kills, and clears infectious and/or dangerous particles and alerts the immune system to the presence of the infection and/or danger. Interestingly, an increasing number of reports have demonstrated a clear role for complement in the adaptive immune system as well. Of note, a number of recent studies have identified previously unknown roles for complement proteins, receptors, and regulators in T cell function. Here, we will review recent data demonstrating the influence of complement proteins C1q, C3b/iC3b, C3a (and C3aR), and C5a (and C5aR) and complement regulators DAF (CD55) and CD46 (MCP) on T cell function during homeostasis and disease. Although new concepts are beginning to emerge in the field of complement regulation of T cell function, future experiments should focus on whether complement is interacting directly with the T cell or is having an indirect effect on T cell function via APCs, the cytokine milieu, or downstream complement activation products. Importantly, the identification of the pivotal molecular pathways in the human systems will be beneficial in the translation of concepts derived from model systems to therapeutic targeting for treatment of human disorders.

Indexed as

ImmunomodulationAnimalsCD55 AntigensComplement C1qComplement C3Complement C5aComplement System ProteinsHomeostasisHumansMembrane Cofactor ProteinT-LymphocytesCD55 AntigensComplement C1qComplement C3Complement C5aComplement System ProteinsMembrane Cofactor ProteinC1qC3C5aCD46DAF

Identifiers

PMID25210145
PMCPMC4197570
OpenAlexW2098065764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.